- Home
- MLP vs FHTX Comparison
MLP vs FHTX Comparison
Compare MLP & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- FHTX
- Stock Information
- Founded
- MLP 1909
- FHTX 2015
- Country
- MLP United States
- FHTX United States
- Employees
- MLP N/A
- FHTX N/A
- Industry
- MLP Real Estate
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- MLP Finance
- FHTX Health Care
- Exchange
- MLP Nasdaq
- FHTX Nasdaq
- Market Cap
- MLP 512.1M
- FHTX 513.7M
- IPO Year
- MLP 1972
- FHTX 2020
- Fundamental
- Price
- MLP $23.75
- FHTX $7.84
- Analyst Decision
- MLP
- FHTX Strong Buy
- Analyst Count
- MLP 0
- FHTX 5
- Target Price
- MLP N/A
- FHTX $16.00
- AVG Volume (30 Days)
- MLP 13.1K
- FHTX 125.4K
- Earning Date
- MLP 11-14-2024
- FHTX 11-04-2024
- Dividend Yield
- MLP N/A
- FHTX N/A
- EPS Growth
- MLP N/A
- FHTX N/A
- EPS
- MLP N/A
- FHTX N/A
- Revenue
- MLP $12,196,000.00
- FHTX $25,515,000.00
- Revenue This Year
- MLP N/A
- FHTX N/A
- Revenue Next Year
- MLP N/A
- FHTX $8.77
- P/E Ratio
- MLP N/A
- FHTX N/A
- Revenue Growth
- MLP 34.84
- FHTX N/A
- 52 Week Low
- MLP $14.03
- FHTX $2.70
- 52 Week High
- MLP $26.46
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- MLP 54.73
- FHTX 44.02
- Support Level
- MLP $22.45
- FHTX $7.33
- Resistance Level
- MLP $24.13
- FHTX $8.25
- Average True Range (ATR)
- MLP 0.99
- FHTX 0.71
- MACD
- MLP 0.01
- FHTX -0.13
- Stochastic Oscillator
- MLP 53.65
- FHTX 21.52
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.